Transcat Inc（TRNS）股票分析TRNSTranscat Inc

Transcat, Inc. is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. It is focused on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceuticals, biotechnology, medical devices, as well as aerospace and defense, and energy and utilities. It provides periodic onsite services, mobile calibration services, pickup and delivery, and in-house services at Calibration Service Centers strategically located across the United States, Puerto Rico, Canada, and Ireland. Its segments include Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting and other related services. The Distribution segment sells and rents national and proprietary branded instruments to customers globally. It operates in the Industrials sector (INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & EL industry).

Transcat Inc is currently trading at $81.92, which is below the analyst price target of $95, indicating potential upside. However, the RSI is at 41.39, suggesting the stock is nearing oversold conditions, but not yet at a strong buy signal. The company reported a significant revenue growth of 22% year-over-year in Q1 2027, which is a positive indicator for long-term investors. The main risk is the recent downgrade by Northland, which reflects concerns about the stock being fully valued in the near term.

2 analysts cover TRNS: 2 rate it Buy, 0 Hold and 0 Sell. The average price target is 100.00.